BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32950263)

  • 1. Pathology-based Biomarkers Useful for Clinical Decisions in Melanoma.
    Torres-Cabala C; Li-Ning-Tapia E; Hwu WJ
    Arch Med Res; 2020 Nov; 51(8):827-838. PubMed ID: 32950263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay.
    Vallée A; Denis-Musquer M; Herbreteau G; Théoleyre S; Bossard C; Denis MG
    PLoS One; 2019; 14(8):e0221123. PubMed ID: 31415669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer.
    Kim HS; Lee H; Shin SJ; Beom SH; Jung M; Bae S; Lee EY; Park KH; Choi YY; Son T; Kim HI; Cheong JH; Hyung WJ; Park JC; Shin SK; Lee SK; Lee YC; Koom WS; Lim JS; Chung HC; Noh SH; Rha SY; Kim H; Paik S
    Oncotarget; 2017 Jun; 8(24):38389-38398. PubMed ID: 28418920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytology specimens offer an effective alternative to formalin-fixed tissue as demonstrated by novel automated detection for ALK break-apart FISH testing and immunohistochemistry in lung adenocarcinoma.
    Rosenblum F; Hutchinson LM; Garver J; Woda B; Cosar E; Kurian EM
    Cancer Cytopathol; 2014 Nov; 122(11):810-21. PubMed ID: 25099128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative Nodules vs Melanoma Arising in Giant Congenital Melanocytic Nevi During Childhood.
    Vergier B; Laharanne E; Prochazkova-Carlotti M; de la Fouchardière A; Merlio JP; Kadlub N; Avril MF; Bodemer C; Lacoste C; Boralevi F; Taieb A; Ezzedine K; Fraitag S
    JAMA Dermatol; 2016 Oct; 152(10):1147-1151. PubMed ID: 27486690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orbital meningeal melanocytoma: Histological, immunohistochemical and molecular characterization of a case and review of the literature.
    Palicelli A; Disanto MG; Panzarasa G; Veggiani C; Galizia G; Dal Cin S; Gruppioni E; Boldorini R
    Pathol Res Pract; 2016 Oct; 212(10):946-953. PubMed ID: 27499153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma.
    Maiques O; Macià A; Moreno S; Barceló C; Santacana M; Vea A; Herreros J; Gatius S; Ortega E; Valls J; Chen BJ; Llobet-Navas D; Matias-Guiu X; Cantí C; Marti RM
    Br J Dermatol; 2017 May; 176(5):1247-1258. PubMed ID: 27718503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma.
    McGregor SM; McElherne J; Minor A; Keller-Ramey J; Dunning R; Husain AN; Vigneswaran W; Fitzpatrick C; Krausz T
    Hum Pathol; 2017 Feb; 60():86-94. PubMed ID: 27771374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.
    Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C
    J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays.
    Fisher KE; Cohen C; Siddiqui MT; Palma JF; Lipford EH; Longshore JW
    Hum Pathol; 2014 Nov; 45(11):2281-93. PubMed ID: 25228337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas.
    Uguen A; Talagas M; Costa S; Samaison L; Paule L; Alavi Z; De Braekeleer M; Le Marechal C; Marcorelles P
    Diagn Pathol; 2015 Jul; 10():121. PubMed ID: 26204954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-label use of common predictive biomarkers in gastrointestinal malignancies: a critical appraisal.
    Tessier-Cloutier B; Cai E; Schaeffer DF
    Diagn Pathol; 2019 Jun; 14(1):62. PubMed ID: 31221175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens.
    Hwang HC; Sheffield BS; Rodriguez S; Thompson K; Tse CH; Gown AM; Churg A
    Am J Surg Pathol; 2016 Jan; 40(1):120-6. PubMed ID: 26448191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making.
    De Paoli-Iseppi R; Johansson PA; Menzies AM; Dias KR; Pupo GM; Kakavand H; Wilmott JS; Mann GJ; Hayward NK; Dinger ME; Long GV; Scolyer RA
    Pathology; 2016 Apr; 48(3):261-6. PubMed ID: 27020503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent In Situ Hybridization in Surgical Pathology Practice.
    Gupta R; Cooper WA; Selinger C; Mahar A; Anderson L; Buckland ME; O'Toole SA
    Adv Anat Pathol; 2018 Jul; 25(4):223-237. PubMed ID: 29727321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Utility and evaluation of immunohistochemical detection of BRAF V600E mutation in melanoma].
    Lyu JJ; Kong YY; Cai X; Shen XX; Lu YW; Ren M
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):548-552. PubMed ID: 28810295
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
    van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
    Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal Cancer Stratification in the Routine Clinical Pathway: A District General Hospital Experience.
    Wedden S; Miller K; Frayling IM; Thomas T; Chefani A; Miller K; Hamblin A; Taylor JC; D'Arrigo C
    Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):e54-e62. PubMed ID: 29985199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a Dual ALK/ROS1 Fluorescent In Situ Hybridization Test in Non-Small-cell Lung Cancer.
    Ginestet F; Lambros L; Le Flahec G; Marcorelles P; Uguen A
    Clin Lung Cancer; 2018 Sep; 19(5):e647-e653. PubMed ID: 29801706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
    Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
    Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.